Short interfering ribonucleic acid (siRNA) for oral administration

Details for Australian Patent Application No. 2007247458 (hide)

Owner Novartis AG

Inventors Natt, Francois Jean-Charles

Agent Davies Collison Cave

Pub. Number AU-B-2007247458

PCT Pub. Number WO2007/128477

Priority 0608838.9 04.05.06 GB

Filing date 2 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 31 March 2011

International Classifications

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/128477 Priority application(s): WO2007/128477

31 March 2011 Application Accepted

  Published as AU-B-2007247458

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007247462-System and method for closed, dripfree and secure transfer of fluids

2007247454-Hollow sleeper